Sustained release of venlafaxine from venlafaxine–montmorillonite–polyvinylpyrrolidone composites
Source abstract
Abstract
Abstract Due to shorter half life of venlafaxine, it is a prime requirement to develop a formulation which could extend the release of venlafaxine in the human body and also eliminate daily multiple dosage of venlafaxine. Montmorillonite (MMT) was used as sustained release carrier for venlafaxine by preparing venlafaxine–MMT by ion exchange. Venlafaxine–MMT was coated with polyvinylpyrrolidone to delay the release of venlafaxine. In vitro releases of venlafaxine from the various formulations were carried out in simulated gastric and intestinal fluids in controlled environment. 50% of venlafaxine was released by intestinal fluid within 5 h, > 95% within 48 h. Venlafaxine–MMT coated with PVP further decreased the release of venlafaxine.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · biodegradable polymer synthesis and properties · Synthesis and properties of polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (24)
Show source-provided references
1. Bergaya · 2006
2. Characterization of venlafaxine hydrochloride and compatibility studies with pharmaceutical excipients10.1007/s10973-009-0282-2 ↗
3. Drug release from matrix devices
4. Comparative evaluation of various structures in polymer controlled drug delivery systems and the effect of their morphology and characteristics on drug release10.1016/j.eurpolymj.2005.11.009 ↗
5. A benefit–risk analysis of once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression
6. Release of cationic drug from loaded clay minerals10.1007/s003960100527 ↗
7. Change in formulation and its potential clinical and pharmacoeconomic value: example of extended release venlafaxine10.1185/03007990902858303 ↗
8. Wy-45, 881 and ciramadol inhibit locus coeruleus neuronal activity10.1016/0014-2999(85)90684-3 ↗
9. Design and fabrication of oral controlled release drug delivery systems
10. Isoconversional kinetics of degradation of polyvinylpyrrolidone used as a matrix for ammonium nitrate stabilization10.1016/j.tca.2008.06.003 ↗
11. Intercalation and control release of vitamin B6 from montmorillonite-vitamin B6 hybrids10.1007/s00396-009-2067-3 ↗
12. A study of montmorillonite intercalated with vitamin B1 as drug carrier10.1016/j.clay.2009.06.001 ↗
13. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate10.1016/j.ijpharm.2009.03.004 ↗
14. Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite10.1002/j.1552-4604.1992.tb03875.x ↗
15. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier10.1016/S0142-9612(01)00325-8 ↗
16. Once daily sustained release tablets of venlafaxine, a novel antidepressant10.1016/S0939-6411(02)00049-8 ↗
17. Loading and delivery of sertraline using inorganic micro and mesoporous materials10.1016/j.ejpb.2006.11.023 ↗
18. Third-generation antidepressants: do they offer advantages over the SSRIs?10.2165/00023210-200115120-00004 ↗
19. Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and wastewater treatment10.1007/BF02704606 ↗
20. Preparation and characterization of phosphonium montmorillonite with enhanced thermal stability10.1016/j.clay.2006.09.012 ↗
21. Synthesis and characterization of organic bentonite using Gujarat and Rajasthan clays
22. Preparation and characterization of venlafaxine hydrochloride-loaded chitosan nanoparticles and in vitro release of drug10.1002/app.29807 ↗
23. Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networks10.1002/jbm.a.30220 ↗
24. Study on ibuprofen/montmorillonite intercalation composites as drug release system10.1016/j.clay.2007.01.012 ↗